Search research articles
Contact Us
Filters
Showing results (1-10 of 629) with videos related to
Page
of 63
Sort By:
Berliner Und Munchener Tierarztliche Wochenschrift
|
April 16, 2015
[The search for novel antibiotics--strategies and current approaches]
Peter Schmid
Clinical Advances in Hematology & Oncology : H&O
|
December 20, 2021
The use of immunotherapy in triple-negative breast cancer
Peter Schmid
ESMO Open
|
November 15, 2018
ESMO 2018 presidential symposium-IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer
Peter Schmid
European Urology
|
April 11, 2007
Re: Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase 1 clinical trial
Hans-Peter Schmid
Drug Research
|
November 17, 2020
Peter Schmid-Grendelmeier
Medizinische Klinik (Munich, Germany : 1983)
|
November 16, 2002
[High-dose chemotherapy in breast cancer]
Peter Schmid, Kurt Possinger
Forum (Genoa, Italy)
|
March 14, 2003
Interactions of antioestrogens and aromatase inhibitors
Peter Schmid, Kurt Possinger
Psychiatric Services (Washington, D.C.)
|
July 3, 2004
Effect of voluntariness of participation in treatment on short-term outcome of inpatients with schizophrenia
Tilman Steinert, Peter Schmid
Psychiatrische Praxis
|
January 17, 2004
[Voluntariness and coercion in patients with schizophrenia]
Tilman Steinert, Peter Schmid
Therapeutische Umschau. Revue Therapeutique
|
July 9, 2019
[Drug hypersensitivity in patients with presumed histamine intolerance and mast cell activation disease]
Peter Schmid-Grendelmeier, Benno Schnyder
Page
of 63
Search research articles
Search
Showing results (1-10 of 629) with videos related to
Sort By:
Page
of 63
Berliner Und Munchener Tierarztliche Wochenschrift
|
April 16, 2015
[The search for novel antibiotics--strategies and current approaches]
Peter Schmid
Clinical Advances in Hematology & Oncology : H&O
|
December 20, 2021
The use of immunotherapy in triple-negative breast cancer
Peter Schmid
ESMO Open
|
November 15, 2018
ESMO 2018 presidential symposium-IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer
Peter Schmid
European Urology
|
April 11, 2007
Re: Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase 1 clinical trial
Hans-Peter Schmid
Drug Research
|
November 17, 2020
Peter Schmid-Grendelmeier
Medizinische Klinik (Munich, Germany : 1983)
|
November 16, 2002
[High-dose chemotherapy in breast cancer]
Peter Schmid, Kurt Possinger
Forum (Genoa, Italy)
|
March 14, 2003
Interactions of antioestrogens and aromatase inhibitors
Peter Schmid, Kurt Possinger
Psychiatric Services (Washington, D.C.)
|
July 3, 2004
Effect of voluntariness of participation in treatment on short-term outcome of inpatients with schizophrenia
Tilman Steinert, Peter Schmid
Psychiatrische Praxis
|
January 17, 2004
[Voluntariness and coercion in patients with schizophrenia]
Tilman Steinert, Peter Schmid
Therapeutische Umschau. Revue Therapeutique
|
July 9, 2019
[Drug hypersensitivity in patients with presumed histamine intolerance and mast cell activation disease]
Peter Schmid-Grendelmeier, Benno Schnyder
Page
of 63